# Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in Malawi

> **NCT01213576** · NA · TERMINATED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 70 (actual)

## Conditions studied

- Lymphatic Filariasis

## Interventions

- **DRUG:** Albendazole 400mg and ivermectin 200mcg/kg
- **DRUG:** Albendazole and ivermectin
- **DRUG:** Albendazole 400mg and ivermectin 200mcg/kg
- **DRUG:** albendazole 800mg and ivermectin 400mcg/kg bi-annually

## Key facts

- **NCT ID:** NCT01213576
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 70 (ACTUAL)
- **Why stopped:** Introduction of National Mass Drug Administration Campaign and failure to identify appropriate participants.
- **Last updated:** 2015-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01213576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01213576, "Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in Malawi". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01213576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*